维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Chambers JT"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Borderline ovarian tumors : a review of treatment 显示文摘	Chambers JT	1989	J Biol Med1989，62，4：	1
2	Neoadjuvant chemo- therapy for advanced ovarian cancer: long-term survival 显示文摘	Schwartz PE Rutherford TJ Chambers JT	1999	Gynecol Oncol1999，72，1：	1
3	Ovarian germ cell malignancies :The Yale University experience 显示文摘	chambtrs SK Chambers JT	1992	Gynecol Oncol1992，45，1：	1
4	Neoadjvant chemotherapy for advanced ovarian cancer: long-term survival显示文摘	Schwartz PE Rutherford TJ Chambers JT	1999	Gynecol Oncol1999，729，1：	1
5	Ovarian germ cell malignanties: the Yale University experience 显示文摘	Schwartz PE Chambers SK Chambers JT	1992	Gynecol Oncol1992，45，：	1
6	Sequelae of lateral ovarian transposition in irradiated cervical cancer patients 显示文摘	Chambers SK Chambers JT Kier R	1991	Int J Radiat Oncol Biol Phys1991，20，6：	1
7	Neoadjuvant chemotherapy for advanced ovarian cancer:long-term survival显示文摘	Schwartz PE Rutherford TJ Chambers JT	1999	Gynecol Oncol1999，72，：	1
8	Sequelae of lateral ovarian transpose-tion in unirradiated cervical cancer patients显示文摘	Chambers SK Chambers JT Holm C	1990	Gyneclooncol1990，39，2：	1
9	Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endomertrial carcinoma,part 1:clinical and histologic correlations显示文摘	Carcangiu ML Chambers JT Voynick IM	1990	Am J Clin Pathol1990，94，：	1
10	Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients 显示文摘	Chambers SK Chambers JT Holm C	1990	Gynecol Oncol1990，39，2：	1
11	Combination chemotherapy with etoposide, cisplatin and doxorubicin in mixed mullerian rumors of the adnexa显示文摘	Cass I Resnik E Chambers JT	1996	Gynecol Oncol1996，61，3：	1
12	A pilot study of topotecan in the treatment of serous carcinoma of the uterus显示文摘	Chambers JT Rutherford TJ Schwartz PE	2003	Int J Gynel Cancer2003，13，2：	1
13	Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival显示文摘	Schwartz PE Rutherford TJ Chambers JT	1999	Gynecol Oncol1999，72，1：	1
14	The activated macrophage colony-stimulating factor( CSF-1 )receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma显示文摘	Toy EP Chambers JT Kacinski BM	2001	Gynecol Oncol2001，80，2：	1
15	Uterine papillary serous carcinoma:a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma显示文摘	Carcangiu ML Chambers JT	1992	Gynecol Oncol1992，47，3：	1
16	Sequelae of lateral ovarian transposition in uninvasived cervical cancer patients 显示文摘	Chambers SK Chambers JT Holm C	1990	Gynecol Oncol1990，39，：	1
17	Erythema annulare centrifugum, snd malignant histiocytosis-report of a case显示文摘	Dodd HJ Kirby JD Chambers JT	1984	Clin Exp Dermatol1984，9，6：	1
18	Neoadjuvant chemotherapy for advanced ovarian cancer显示文摘	Sehwartz PE chambers JT Makuch R	1994	Gynecol Oncol1994，53，1：	1
19	Early detection and screening for ovarian cancer显示文摘	Chambers JT Taylor KJ	1995	J cell Biochem(Suppl)1995，23，233：	1
20	Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma,part 1:clinical and histologic correlations显示文摘	Carcangiu ML Chambers JT Voynick IM		0，，03：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示